An interventional study of Fecal calprotectin dosage and Questionnaire and interview with parents in Functional Gastrointestinal Disorders and Infant, Newborn, Diseases, sponsored by Centre Hospitalier Universitaire de Besancon. Not yet recruiting. Open to participants aged 0 Months to 4 Months. Per ClinicalTrials.gov, last updated 2023-07-07.
Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Other
There is a high prevalence of FGID among infants : 30 % for regurgitations, 20 % for colitis , 15 % for functional constipation.This represents a frequent motive for pediatrics consultation : 23 to 28 % of medical consultations in this population are consequent to gastrointestinal symptoms among infants aged under 4 months old. This can lead to numerous inappropriate or unrecommended medication prescriptions.
Currently, fecal calprotectin threshold are only validated by science societies for children aged 5 years old and more. This study aims to quantify the difference of fecal calprotectin between a population of infants for whom no FGID has been finally detected, and a population of infants for whom FGID have been detected during the gastro-pediatrics consultation, , in order to later determine wether it is possible to validate a threshold in a population of infants aged under 4 months old.
628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.
This study's planned enrollment of 100 is above the median of 77 across 422 interventional studies indexed under Gastrointestinal Diseases.
Browse Gastrointestinal Diseases studies →Centre Hospitalier Universitaire de Besancon is the lead sponsor of 439 studies on the registry; 97 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Infants \< 4 months old presenting one or several Functional GastroIntestinal Disorder(s)
Other: Fecal calprotectin dosage · Other: Questionnaire and interview with parents
Infants \< 4 months old without any Functional GastroIntestinal Disorder
Other: Fecal calprotectin dosage · Other: Questionnaire and interview with parents
Dosing calprotectin in infants' feces + questionnaire/interview with parents
Dosing calprotectin in infants' feces + questionnaire/interview with parents
Quantification of fecal calprotectin concentration difference
Quantification in µg/g feces of fecal calprotectin concentration difference between infants aged under 4 months old suffering from Functional Gastrointestinal disorders (FGID) and infants aged under 4 months old free from disorders
Time frame: 1 month
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Besancon